Literature DB >> 28265049

The ethics of betel nut consumption in Taiwan.

Joseph Tham1, Geoffrey Sem2, Eugene Sit3, Michael Cheng-Tek Tai4.   

Abstract

The ethics of betel nut use in Taiwan are examined in this article. It first presents scientific facts about the betel quid, its consumption and negative health consequences and then analyses the cultural background and economic factors contributing to its popularity in Asia. Governmental and institutional attempts to curb betel nut cultivation, distribution and sales are also described. Finally, the bioethical implications of this often ignored subject are considered. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  History of Health Ethics/Bioethics; Informed Consent; Social Aspects; Substance Abusers/Users of Controlled Substances

Mesh:

Year:  2017        PMID: 28265049     DOI: 10.1136/medethics-2016-103990

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  3 in total

1.  Cumulative Betel Quid Chewing and the Risk of Significant Liver Fibrosis in Subjects With and Without Metabolic Syndrome.

Authors:  Yu-Tsung Chou; Zih-Jie Sun; Wei-Chen Shen; Yi-Ching Yang; Feng-Hwa Lu; Chih-Jen Chang; Chung-Yi Li; Jin-Shang Wu
Journal:  Front Nutr       Date:  2022-02-11

2.  Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region.

Authors:  Cheng-Ping Wang; Yih-Leong Chang; Tseng-Cheng Chen; Chen-Tu Wu; Jenq-Yuh Ko; Tsung-Lin Yang; Pei-Jen Lou
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

3.  Sex Differences in the Heterogeneous Dynamic Incidence of Oral Cancer: A Comparison between Taiwan and Thailand.

Authors:  Pallop Siewchaisakul; Pongdech Sarakarn; Patravoot Vatanasapt; Sam Li-Sheng Chen; Amy Ming-Fang Yen
Journal:  Biomed Res Int       Date:  2020-09-15       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.